Renal MR angiography: current debates and developments in imaging of renal artery stenosis

Intraindividual Comparison of High-Spatial-Resolution Abdominal MR Angiography at 1.5 T and 3.0 T: Initial Experience

PURPOSE

To prospectively compare three-dimensional (3D) contrast material-enhanced abdominal magnetic resonance (MR) angiography at 1.5 and 3.0 T intraindividually in healthy volunteers.

MATERIALS AND METHODS

After institutional review board approval and informed consent were obtained, 15 healthy male volunteers (age range, 24-41 years) underwent one abdominal 3D contrast-enhanced MR angiographic examination each at 1.5 and 3.0 T in random order. Fast 3D gradient-echo sequence with parallel imaging acceleration factor of three was used for MR angiography; acquired spatial resolutions were 1x0.8x1 mm3 (imaging time, 19 seconds) at 1.5 T and 0.9x0.8x0.9 mm3 (imaging time, 18 seconds) at 3.0 T. With the latter, volume of the 3D slab was 8% larger. At 1.5 T, 20-mL bolus of gadobenate dimeglumine was delivered at 2 mL/sec; at 3.0 T, 15-mL bolus was delivered at 2.5 mL/sec. Two blinded radiologists rated image quality of aorta and proximal renal arteries in consensus with five-point scale (4=very good, 0=nondiagnostic) according to sequence and in direct intraindividual comparison. Visibility of proximal and segmental renal arteries was rated with three-point scale (3=completely visible, 1=nonvisible). Signal-to-noise ratio (SNR) was determined with phantoms. For statistical analysis of the SNRs, t tests were used.

RESULTS

All MR angiographic measurements were diagnostic. Median score for image quality at both field strengths was 4. Depiction of proximal renal arteries was rated 3 at both field strengths. The visibility of the distal renal arteries was better at 3.0 T (median score, 3) than at 1.5 T (median score, 2). With direct comparison, 3.0-T MR angiography was better in 14 of 15 cases; no field strength was preferred in the other case. Mean SNR was significantly (P<.001) higher at 3.0 T (17.8+/-0.09 [standard deviation]) than at 1.5 T (11.9+/-0.10).

CONCLUSION

MR angiography at 3.0 T provided better vessel visibility and SNR than did that at 1.5 T, although voxel size and imaging time were reduced.

Abdominal and Pelvic MR Angiography

Currently, 3T MR scanners hold 10% of the market with rising market share. Angiographic exams in particular benefit directly from the higher field strength. The theoretically doubled signal-to-noise ratio at 3T allows for abdominal magnetic-resonance angiography (MRA) exams with submillimeter spatial resolution with acquisition times of less than 20 seconds. Because of altered longitudinal relaxation times, MRA exams can be performed with a significantly reduced amount of contrast agents. This review describes the current technical concepts and outlines typical sequence parameters for abdominal and pelvic MRA. The choice of contrast agents for abdominal MRA is discussed in detail. This article also provides an outlook to new technical concepts that are already at the horizon of MRA.

Fibromuscular Dysplasia of the Main Renal Arteries: Comparison of Contrast-enhanced MR Angiography with Digital Subtraction Angiography

PURPOSE

To retrospectively evaluate the sensitivity and specificity of contrast material-enhanced magnetic resonance (MR) angiography by using digital subtraction angiography as the reference standard in patients with hypertension and renal artery fibromuscular dysplasia (FMD).

MATERIALS AND METHODS

Institutional review board approval was obtained, with waiver of informed consent. The results of renal contrast-enhanced MR angiography were retrospectively analyzed in 25 patients with hypertension (24 women, one man; mean age, 48 years +/- 19 [standard deviation]; age range, 18-72 years) who had FMD diagnosed on the basis of clinical and angiographic features. All examinations were performed at 1.5 T. Results were analyzed by two readers, and a third reader established a consensus in case of discrepancy. Sensitivity, specificity, and 95% confidence intervals (CIs) were calculated for FMD and for each possible type of FMD lesion ("string of pearls" appearance, stenosis, and aneurysm). A linear-weighted kappa statistic was calculated to determine agreement between digital subtraction angiography and contrast-enhanced MR angiography for the diagnosis of FMD and to determine inter- and intraobserver agreement regarding FMD diagnosis.

RESULTS

Fifty main renal arteries were analyzed, 35 of which demonstrated abnormal arteriographic features of FMD (stenosis, 22 arteries; string of pearls, 21 arteries; and aneurysm, four arteries). The sensitivity and specificity of contrast-enhanced MR angiography for the diagnosis of FMD were 97% (95% CI: 83%, 100%) and 93% (95% CI: 66%, 100%), respectively. Sensitivity was 68% (95% CI: 83%, 100%), 95% (95% CI: 74%, 100%), and 100% (95% CI: 40%, 100%) for the diagnosis of stenosis, string of pearls, and aneurysm, respectively. Linear-weighted kappa statistics for inter- and intraobserver agreement regarding FMD diagnosis were 0.63 and 0.92, respectively.

CONCLUSION

In patients with renal FMD, contrast-enhanced MR angiography can reliably facilitate diagnosis by demonstrating characteristic lesions.

Functional magnetic resonance imaging in renal artery stenosis

Renal artery stenosis (RAS) is the leading cause of secondary hypertension. Magnetic resonance (MR) imaging and in particular MR angiography have evolved into important diagnostic tools for the detection and grading of RAS due to the lack of ionizing radiation and nephrotoxic contrast agent. This review describes state-of-the-art MR angiographic techniques and introduces the reader to current concepts of RAS grading with MR angiography. We compare MR angiography with conventional angiography and intravascular ultrasound as a standard of reference. The technical basis of functional imaging techniques such as arterial spin labeling perfusion measurements, contrast-enhanced perfusion measurements, and MR flow measurements are explained. Their value for the grading and detection of RAS and for the differentiation of renovascular from renal parenchymal disease is discussed. An overview about imaging during and after interventional therapy of RAS and an introduction to the current understanding of prediction of successful interventional therapy finishes this review.

Renal Arteries: Comparison of Steady-State Free Precession MR Angiography and Contrast-enhanced MR Angiography

All participants provided informed consent to participate in this study, which was approved by the institutional review board. Breath-hold three-dimensional (3D) steady-state free precession (SSFP) magnetic resonance (MR) angiography was compared with 3D contrast material-enhanced MR angiography in patients suspected of having renal artery stenosis. Two radiologists assessed visualization of renal arteries and detection of vascular disease. With SSFP MR angiography, 39 of 41 renal arteries in 19 patients were correctly detected. Relevant stenoses were correctly identified with SSFP MR angiography in two patients. In two patients, SSFP MR angiographic data sets led to false-positive overgrading of vascular disease. Fast breath-hold 3D SSFP MR angiography appears to be feasible for MR angiography of renal arteries.

Magnetic Resonance Imaging of Renal Disease: Recent Developments and Future Applications

Magnetic resonance imaging (MRI) offers the ability to non-invasively assess parenchymal and vascular renal disease. Indications for renal MRI include the evaluation of renal masses, urinary obstruction and infection, renal vasculature, and the health of transplant kidneys. The potential of MR angiography to replace invasive conventional x-ray angiography has been recognized for many years. Recent developments in MRI resulting from fast MR systems with faster gradients, new surface coil designs and the latest sequence developments coupled with innovative contrast agent administration strategies have prompted substantial progress of MRI in the diagnosis of renal disease. The goal of this article is to present the current state of MRI in diagnosing renal disease, with an emphasis on the latest developments in the evaluation of renal vascular disease.

Renal Artery Stenosis: Functional Assessment with Dynamic MR Perfusion Measurements—Feasibility Study

PURPOSE

To prospectively assess feasibility of renal magnetic resonance (MR) perfusion measurement method based on turbo fast low-angle shot sequences for grading effect of renal artery stenosis (RAS) on parenchymal perfusion.

MATERIALS AND METHODS

Institutional review board approved this study, and patients gave written consent. Seventy-three patients (34 male, 39 female; age range, 17-84 years) who were clinically suspected of having RAS underwent contrast material-enhanced (gadodiamide) saturation-recovery turbo fast low-angle shot imaging for measurement of renal perfusion and high-spatial-resolution MR angiography for RAS detection and grading. Degree of stenosis was evaluated as high grade (>/=75% stenosis), low to intermediate grade (>0% to <75% stenosis), or absent. High temporal resolution of the turbo fast low-angle shot sequence allowed acquisition of an exact first-pass tracing of the contrast agent bolus from which a signal intensity (SI)-time curve was derived. On the basis of this curve, mean transit time (MTT) of the contrast agent bolus, maximal upslope (MUS) of the curve, maximum SI, and time to SI peak (TTP) were calculated with a gamma variate fit. Wilcoxon rank sum test, Pearson product moment correlation, and paired t test were used for statistical analysis.

RESULTS

Twenty-four renal arteries had high-grade RAS, 12 renal arteries had low- to intermediate-grade RAS, and 104 renal arteries had no RAS. Significant differences between patients without stenoses or with low- to intermediate-grade stenoses and patients with high-grade stenoses were found for MTT, MUS, and TTP (P < .001). Perfusion parameters were correlated with patients' serum creatinine levels, and significant correlations were found for MTT (r = 0.41), MUS (r = 0.48), and TTP (r = 0.4), with P < .001.

CONCLUSION

MR perfusion parameters can be used to assess effect of RAS on parenchymal perfusion. Perfusion measurements reflect renal function as measured with serum creatinine levels.

Ischemic nephropathy: Detection and therapeutic intervention

Although the real prevalence of ischemic nephropathy as a cause of end-stage renal disease is unknown, its incidence has increased in past years. The diagnosis of this pathology requires that a number of functional and anatomic tests be carried out. The initial approach should be to perform duplex Doppler ultrasonography which, besides providing data on the size and extent of the stenosis, enables the intrarenal resistive index to be estimated to determine the pattern of renal parenchyma injury and the expected progression if revascularized. The most frequently used morphologic techniques are magnetic resonance angiography and computer tomography angiography. In the event of ischemic neuropathy, it is necessary to perform a renal arteriography regardless of the inherent risks of contrast toxicity or atheroembolism. Various therapeutic options are reviewed, with emphasis on percutaneous transluminal renal angiography plus stent as the first indication. Even though initial reports were contradictory, several meta-analyses have concluded that better blood pressure control and renal function improvement are achieved with percutaneous transluminal renal angiography plus stent than with conventional medical therapy. Surgical revascularization is preferable in patients with severe aorto-iliac pathology and renal artery ostium complete thrombosis. The risks and benefits of these procedures must be evaluated on an individual basis.

High-Spatial-Resolution MR Angiography of Renal Arteries with Integrated Parallel Acquisitions: Comparison with Digital Subtraction Angiography and US

PURPOSE

To retrospectively compare three-dimensional gadolinium-enhanced magnetic resonance (MR) angiography, performed with an integrated parallel acquisition technique for high isotropic spatial resolution, with selective digital subtraction angiography (DSA) and intravascular ultrasonography (US) for accuracy of diameter and area measurements in renal artery stenosis.

MATERIALS AND METHODS

The study was approved by the institutional review board, and consent was obtained from all patients. Forty-five patients (17 women, 28 men; mean age, 62.2 years) were evaluated for suspected renal artery stenosis. Three-dimensional gadolinium-enhanced MR angiograms were acquired with isotropic spatial resolution of 0.8 x 0.8 x 0.9 mm in 23-second breath-hold with an integrated parallel acquisition technique. In-plane diameter of stenosis was measured along vessel axis, and perpendicular diameter and area of stenosis were assessed in cross sections orthogonal to vessel axis, on multiplanar reformations. Interobserver agreement between two radiologists in measurements of in-plane and perpendicular diameters of stenosis and perpendicular area of stenosis was assessed with mean percentage of difference. In a subset of patients, degree of stenosis at MR angiography was compared with that at DSA (n = 20) and intravascular US (n = 11) by using Bland-Altman plots and correlation analyses.

RESULTS

Mean percentage of difference in stenosis measurement was reduced from 39.3% +/- 78.4 (standard deviation) with use of in-plane views to 12.6% +/- 9.5 with use of cross-sectional views (P < .05). Interobserver agreement for stenosis grading based on perpendicular area of stenosis was significantly better than that for stenosis grading based on in-plane diameter of stenosis (mean percentage of difference, 15.2% +/- 24.2 vs 54.9% +/- 186.9; P < .001). Measurements of perpendicular area of stenosis on MR angiograms correlated well with those on intravascular US images (r(2) = 0.90).

CONCLUSION

Evaluation of cross-sectional images reconstructed from high-spatial-resolution three-dimensional gadolinium-enhanced MR renal angiographic data increases the accuracy of the technique and decreases interobserver variability.

Renal magnetic resonance imaging

PURPOSE OF REVIEW

Current magnetic resonance imaging systems allow the visualization of normal and diseased kidney, with exquisite resolution of renal structures. Dynamic contrast magnetic resonance imaging has the potential, unique among all noninvasive modalities, to differentiate diseases that affect different portions of the vascular-nephron system. This article reviews the most important recently published studies in selected topics chosen because of their clinical relevance or potential for technical developments.

RECENT FINDINGS

Magnetic resonance imaging is used increasingly to evaluate renal masses, the prenatal genitourinary system, urinary obstruction and infection, renal vasculature, and the kidneys of transplant donors and recipients. Dynamic contrast magnetic resonance renography based on gadolinium chelated to diethylenetriamine pentaacetic acid, a safe (non-nephrotoxic) paramagnetic agent, emerges as the functional renal imaging modality of choice. Both perfusion and filtration rates can be assessed in individual kidney.

SUMMARY

Magnetic resonance imaging has the potential to provide a complete anatomic, physiologic, kidney-specific evaluation. With future advances in automated image analysis methods we can expect functional renal magnetic resonance imaging to play an influential role in management of renal disease.

Atherosclerotic renal artery stenosis: current status and future directions

PURPOSE OF REVIEW

Atherosclerotic renal artery stenosis is a common, progressive problem that increases in prevalence with age. It can have important clinical consequences such as hypertension, pulmonary edema, and renal failure. In addition, it is associated with increased cardiovascular mortality. The purpose of this review is to describe the current status of knowledge and future directions for this evolving field.

RECENT FINDINGS

In patients who are suspected of having the disease, duplex Doppler ultrasound and magnetic resonance angiography remain the most promising noninvasive screening tests. Percutaneous revascularization continues to advance, and technical success is possible in the vast majority of patients. Revascularization for hypertension is of modest clinical benefit. Limited information is available on the effect of revascularization on preservation of renal function or cardiovascular events and mortality.

SUMMARY

Further studies are still needed focusing on the identification of which patients will derive benefit from percutaneous revascularization and whether intervention provides an advantage over medical therapy, particularly with respect to preservation of renal function and reduction in cardiovascular morbidity and mortality.

Advances in vascular imaging

The improvement of vascular imaging has allowed the acquisition of vascular images with higher resolution while minimizing the risks and discomfort to patients. As imaging developments continue to progress, establishment of valid clinical-based evidence, before the application of each innovation, will assure maintenance of the current trend. Also, as the vascular surgeon adopts a more comprehensive approach in the care of vascular patients, a high-quality endovascular suite will provide an environment for integration of both traditional open and evolving endovascular procedures.

An MRA study of vascular stenosis in a pig model using CH3-DTPA-Gd (NMS60) and Gd-DTPA

PURPOSE

This study used an experimental arterial stenosis model in pigs to evaluate the utility of a new medium-weight MRI contrast agent, NMS60 (a synthetic oligomeric Gd complex containing three Gd(3+) atoms, molecular weight of 2158 Da) compared to Gd-DTPA for contrast-enhanced MRA.

MATERIALS AND METHODS

We used six male white hybrid pigs. Under anesthesia, one femoral artery was exposed and an inflatable cuff placed around it. The cuff was tightened around the vessel until 80-90% stenosis was achieved using digital subtraction angiography as a guide. Animals were then immediately transferred to the MRI scanner and images acquired pre- and postcontrast injection (0.1 or 0.2 mmol Gd/kg Gd-DTPA or NMS60, as a rapid bolus) using high-resolution and dynamic MRA.

RESULTS

The dynamic MRA scans acquired during contrast bolus injection clearly showed the stenosed femoral artery as a segment of close to zero enhancement during the arterial phase of the bolus transit, while on the high-resolution scans the stenosis was difficult to detect due to venous signal contamination. The signal-to-noise at peak enhancement on the dynamic scans was significantly greater with 0.1 mmol Gd/kg NMS60 compared to 0.1 mmol Gd/kg Gd-DTPA (14.6 vs. 9.9, P < .05) and not significantly greater than 0.2 mmol Gd/kg (14.6 vs. 12.8).

DISCUSSION AND CONCLUSION

This new medium-weight contrast agent demonstrated significantly greater enhancement than Gd-DTPA and may be valuable to aid detection of vascular stenosis in humans.